Approved Study Database

Ref. No. Scientific Title Principal investigator
2026.162 A Novel Combinatorial Anti-Cancer Therapeutic Platform: Development and Pre-Clinical Evaluation of siNIP7-Lipid Nanoparticles Combined with Akt Inhibitor Prof. Tse Gary Man Kit
2025.084 Deciphering the Role of BMP8A in Breast Cancer Associated with Fibrotic Focus and Clinical Insights Prof. TSE Gary
2024.508 Patient-derived organoid platform for evaluating drug sensitivity and identifying long noncoding RNA LINC01235 as a new RNA therapeutics to overcome chemoresistance in breast cancer Prof. TSE Gary Man Kit
2024.404 Outcome prediction of breast cancer patients with neoadjuvant therapy Prof. TSE Gary Man Kit
謝文杰
2024.405 FOXC1 regulatory network in trastuzumab resistance of HER2+ breast cancer and potential clinical values Dr. TSE Gary Man Kit
謝文杰
2022.386 An individualized treatment prediction for breast cancer patients with neoadjuvant therapy Dr. TSE Gary Man Kit
謝文杰
2022.015 Artificial intelligence based approach for outcome prediction in breast cancer patient with neoadjuvant treatment Prof. TSE Gary
謝文杰
2021.726 NIP7 as a novel therapeutic target for triple-negative breast cancer Prof. Tse Gary Man Kit
謝文杰
2021.102 Role and mechanisms of TUBB2B in promoting brain metastatic outgrowth of breast cancer Prof. TSE Gary Man Kit
謝文杰
2020.281 Predicting future malignancy in benign breast disease Dr. TSE Gary M
謝文杰
2019.444 Characterization of fibrotic focus as a prognostic marker in breast cancer Dr. TSE Gary
謝文杰
2019.422 Electrocardiographic and echocardiographic indices of atrial and ventricular remodelling in patients with heart failure and valvular heart disease Prof. TSE Gary
2019.361 Evaluating the aetiologies of ventricular arrhythmias: a comparative study Dr. TSE Gary
2019.338 ECG abnormalities in patients with Brugada syndrome, long QT syndrome, myocarditis, endocarditis and myocardial infarction and their relationships to arrhythmic and mortality outcomes Dr. TSE Gary
2019.335 Understanding the molecular diversity of breast cancer and its clinical implication Dr. TSE Gary Man Kit
謝文杰
2018.643 Investigation of cardiovascular outcomes of in-patients with pro-inflammatory states: a comparative study based on different drug classes Dr. TSE Gary
2018.644 Cardiovascular adverse outcome associated with the use of anti-PD-1/PD-L1 antibodies Dr. TSE Gary
2018.655 Characterization of electrophysiological and mechanical properties in bioengineered tissues using induced pluripotent stem cell-derived cardiomyocytes from Brugada and dilated cardiomyopathy patients Dr. TSE Gary
2018.309 Investigation of the association between haematological parameters and clinical outcomes of in-patients with pro-inflammatory state Dr. TSE Gary
2017.457 Diagnostic and prognostic values of longitudinal strain by automated function imaging in acute coronary syndrome Prof. TSE Gary
2016.580 Predicting malignancy in patients with atypical ductal hyperplasia on core needle biopsy of the breast Dr. TSE Gary M.K.
謝文杰
2016.518 Reversal of doxorubicin resistance in breast cancer stem cells Dr. TSE Gary M.K.
謝文杰
2016.507 Clinical, pathological and treatment issues of primary breast lymphoma Dr. TSE Gary M.K.
謝文杰
2015.668 Establishment of a local breast-cancer single nucleotide polymorphism (SNP) database for prediction of cancer risk in Hong Kong Dr. TSE Gary MK
謝文杰
2015.488 Predicting clinical behaviour of breast phyllodes tumor Dr. TSE Gary M.K.
謝文杰
2015.377 Application of digital PCR in pre-operative diagnosis of breast cancer Dr. TSE Gary M.K.
謝文杰
2015.310 Establishment and evaluation of cell line from phyllodes tumor of breast as model for pre-clinical studies Dr. TSE Gary MK
謝文杰
2014.500 An investigation of amyloid precursor protein in triple negative breast cancers and its potential clinical value Dr. TSE Gary M.K.
2011.199 Molecular subtypes of breast cancer in a large cohort of Chinese patients: correlation with biomarkers expression, prognosis and clinical outcomes Dr. TSE Gary M K
2011.206 The role of microRNAs in the pathogenesis of Phyllodes tumor of breast Dr. TSE Gary M.K.
2008.310 A Retropsective Study to Investigate the Prognostic Significance of p63 EGFR and HER2 Expression in Patients with Head and Neck Squamous Cell Carcinoma TSE Gary

Page 1 of 1.